Michelle Obama Net Worth: How did Barack Obama's wife make her wealth?
Michelle Obama has left a very important legacy in the United States, especially in the health sector with medical care and ...
Hosted on MSN3d
Novo Nordisk Before Q4 Earnings: How Should Investors Play the Stock?
Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks ...
Novo Nordisk Has Probably Declined Enough
Novo Nordisk's recent decline suggests it may be a Buy again, with strong growth prospects in diabetes and obesity treatments ...
What Is Front-of-Package Food Labeling? And Will it Help?
The FDA says new labels will make it easier to spot harmful ingredients. A UVA nutritionist suggests taking a holistic ...
Stacker on MSN3d
Diabetes and other chronic conditions are becoming common. Here's how public health efforts can help bring rates down.
Dialysis Centers used data from the Centers for Disease Control and Prevention to examine the prevalence of chronic diseases ...
C.D.C. Site Restores Some Purged Files After ‘Gender Ideology’ Ban Outcry
Intense backlash prompted the reinstatement of some online resources. But guidelines for safe contraception and information ...
Prescriptions for obesity management drugs increasing
Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online ...
Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024
Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast. Sales of ...
Heartland4d
Congressman Proposes Cure for U.S. Health Care System
Rep. Chip Roy (R-TX) issued a diagnosis for America’s broken health care system, and the congressman says the problem isn’t what people think.
Human Microbiome Market Size to Surge to $4.85 Billion by 2031, Fuelled by Research and Innovation - Exclusive Report by The Insight Partners
The human microbiome market share is expected to reach US$ 4.85 billion by 2031, driven by increased investments in research, ...
Novo Nordisk: Among The Best Opportunities Of The Moment (Rating Upgrade)
Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.
About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds
A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a ...